{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T18:44:09Z","timestamp":1792867449039,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Photodiagnosis and Photodynamic Therapy"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.pdpdt.2016.09.002","type":"journal-article","created":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T01:02:51Z","timestamp":1473382971000},"page":"205-207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["PDT and emerging therapies for Actinic Keratosis\u2014A resource letter"],"prefix":"10.1016","volume":"17","author":[{"given":"Jos\u00e9 D. Vollet","family":"Filho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cintia T.","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilde H.","family":"Buzza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Carbinatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanderlei S.","family":"Bagnato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron R.","family":"Allison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pdpdt.2016.09.002_bib0005","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.pdpdt.2016.04.017","article-title":"Photodynamic therapy in the management of actinic keratosis: retrospective evaluation of outcome","volume":"17","author":"Jerjes","year":"2017","journal-title":"Photodiagn. Photodyn. Ther."},{"issue":"2","key":"10.1016\/j.pdpdt.2016.09.002_bib0010","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jval.2015.11.014","article-title":"Evaluation of resource utilization and treatment patterns in patients with actinic keratosis in the United States","volume":"19","author":"Asche","year":"2016","journal-title":"Value Health"},{"issue":"Suppl. 1","key":"10.1016\/j.pdpdt.2016.09.002_bib0015","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.jaad.2012.09.052","article-title":"Prevalence and awareness of actinic keratosis: barriers and opportunities","volume":"68","author":"Rosen","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"issue":"1","key":"10.1016\/j.pdpdt.2016.09.002_bib0020","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.pdpdt.2009.12.004","article-title":"Taking treatment decisions in non-melanoma skin cancer\u2013the place for topical photodynamic therapy (PDT)","volume":"7","author":"Sidoroff","year":"2010","journal-title":"Photodiagn. Photodyn. Ther."},{"issue":"8","key":"10.1016\/j.pdpdt.2016.09.002_bib0025","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1038\/jid.2013.134","article-title":"Prevalence of actinic keratosis and its risk factors in the general population: the Rotterdam study","volume":"133","author":"Flohil","year":"2013","journal-title":"J. Invest. Dermatol."},{"issue":"3","key":"10.1016\/j.pdpdt.2016.09.002_bib0030","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2340\/00015555-2278","article-title":"Laser-mediated photodynamic therapy: an alternative treatment for actinic keratosis?","volume":"96","author":"Kessels","year":"2016","journal-title":"Acta Derm. Venereol."},{"issue":"3","key":"10.1016\/j.pdpdt.2016.09.002_bib0035","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1590\/S0365-05962012000300012","article-title":"Actinic keratosis: a clinical and epidemiological revision","volume":"87","author":"Schmitt","year":"2012","journal-title":"An. Bras. Dermatol."},{"key":"10.1016\/j.pdpdt.2016.09.002_bib0040","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2147\/CCID.S28905","article-title":"New developments in the treatment of actinic keratosis: focus on ingenol mebutate gel","volume":"5","author":"Berman","year":"2012","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"issue":"1","key":"10.1016\/j.pdpdt.2016.09.002_bib0045","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s13555-015-0070-9","article-title":"Primary care review of actinic keratosis and its therapeutic options: a global perspective","volume":"5","author":"Chetty","year":"2015","journal-title":"Dermatol. Ther. (Heidelb.)"},{"issue":"10","key":"10.1016\/j.pdpdt.2016.09.002_bib0050","first-page":"2365","article-title":"Cryosurgery for common skin conditions","volume":"69","author":"Andrews","year":"2004","journal-title":"Am. Fam. Phys."},{"issue":"2","key":"10.1016\/j.pdpdt.2016.09.002_bib0055","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1365-2133.2006.07692.x","article-title":"British association of dermatologists therapy guidelines and audit subcommittee: guidelines for the management of actinic keratoses","volume":"156","author":"de Berker","year":"2007","journal-title":"Br. J. Dermatol."},{"issue":"2","key":"10.1016\/j.pdpdt.2016.09.002_bib0060","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/jdv.12530","article-title":"Physician perceptions and experience of current treatment in actinic keratosis","volume":"29","author":"Stockfleth","year":"2015","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.pdpdt.2016.09.002_bib0065","unstructured":"Imiquimod (Aldara, Zyclara), drug monograph. http:\/\/www.medicinenet.com\/imiquimod-topical\/article.htm, 2016 (June 19)."},{"issue":"1","key":"10.1016\/j.pdpdt.2016.09.002_bib0070","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.det.2006.09.006","article-title":"Photodynamic therapy for actinic keratoses","volume":"25","author":"Kalisiak","year":"2007","journal-title":"Dermatol. Clin."},{"issue":"9","key":"10.1016\/j.pdpdt.2016.09.002_bib0075","doi-asserted-by":"crossref","first-page":"R61","DOI":"10.1088\/0031-9155\/53\/9\/R01","article-title":"The physics: biophysics and technology of photodynamic therapy","volume":"53","author":"Wilson","year":"2008","journal-title":"Phys. Med. Biol."},{"issue":"12","key":"10.1016\/j.pdpdt.2016.09.002_bib0080","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/jnci\/90.12.889","article-title":"Photodynamic therapy","volume":"90","author":"Dougherty","year":"1998","journal-title":"J. Natl. Cancer Inst."},{"issue":"2","key":"10.1016\/j.pdpdt.2016.09.002_bib0085","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3315\/jdcr.2015.1199","article-title":"How to treat actinic keratosis? An update","volume":"9","author":"Costa","year":"2015","journal-title":"J. Dermatol. Case Rep."},{"issue":"1","key":"10.1016\/j.pdpdt.2016.09.002_bib0090","first-page":"1","article-title":"Review of photodynamic therapy in actinic keratosis and basal cell carcinoma","volume":"4","author":"Ericson","year":"2008","journal-title":"Ther. Clin. Risk Manag."},{"issue":"1","key":"10.1016\/j.pdpdt.2016.09.002_bib0095","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.det.2006.09.009","article-title":"Methyl aminolevulinate: actinic keratoses and Bowen\u2019s disease","volume":"25","author":"Morton","year":"2007","journal-title":"Dermatol. Clin."},{"issue":"1","key":"10.1016\/j.pdpdt.2016.09.002_bib0100","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1572-1000(04)00007-9","article-title":"Photosensitizers in clinical PDT","volume":"1","author":"Allison","year":"2004","journal-title":"Photodiagn. Photodyn. Ther."},{"issue":"6","key":"10.1016\/j.pdpdt.2016.09.002_bib0105","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.clindermatol.2013.05.007","article-title":"Solar keratoses: photodynamic therapy, cryotherapy, 5-fluorouracil, imiquimod, diclofenac, or what? Facts and controversies","volume":"31","author":"Schmitt","year":"2013","journal-title":"Clin. Dermatol."},{"issue":"4","key":"10.1016\/j.pdpdt.2016.09.002_bib0110","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.pdpdt.2015.10.006","article-title":"Pre-treatment protoporphyrin IX concentration in actinic keratosis lesions may be a predictive biomarker of response to aminolevulinic-acid based photodynamic therapy","volume":"12","author":"Kanick","year":"2015","journal-title":"Photodiagn. Photodyn. Ther."},{"issue":"1","key":"10.1016\/j.pdpdt.2016.09.002_bib0115","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/ajd.12295","article-title":"Treatment of face and scalp solar (actinic) keratosis with daylight\u2010mediated photodynamic therapy is possible throughout the year in Australia: evidence from a clinical and meteorological study","volume":"57","author":"Spelman","year":"2016","journal-title":"Australas. J. Dermatol."},{"issue":"2","key":"10.1016\/j.pdpdt.2016.09.002_bib0120","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2340\/00015555-2205","article-title":"Photodynamic therapy for actinic keratoses: a randomized prospective non-sponsored cost-effectiveness study of daylight-mediated treatment compared with light-emitting diode treatment","volume":"96","author":"Neittaanmaki-Perttu","year":"2016","journal-title":"Acta Derm. Venereol."},{"issue":"1","key":"10.1016\/j.pdpdt.2016.09.002_bib0125","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/jdv.13327","article-title":"Daylight photodynamic therapy with MAL cream for large-scale photodamaged skin based on the concept of \u2018actinic field damage\u2019: recommendations of an international expert group","volume":"30","author":"Philipp-Dormston","year":"2016","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"3","key":"10.1016\/j.pdpdt.2016.09.002_bib0130","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3390\/ijms17030309","article-title":"Alternatives to outdoor daylight illumination for photodynamic therapy-use of greenhouses and artificial light sources","volume":"17","author":"Lerche","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.pdpdt.2016.09.002_bib0135","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/phpp.12221","article-title":"Daylight-mediated photodynamic therapy for actinic damage in Latin America: consensus recommendations","volume":"32","author":"Grinblat","year":"2016","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"issue":"2","key":"10.1016\/j.pdpdt.2016.09.002_bib0140","doi-asserted-by":"crossref","first-page":"407","DOI":"10.17554\/j.issn.1819-6187.2016.04.79","article-title":"Clinical protocol standardized in a public health system using a prototype for actinic keratosis and field cancerization treatment","volume":"4","author":"Blanco","year":"2016","journal-title":"J. Tumor"},{"key":"10.1016\/j.pdpdt.2016.09.002_bib0145","article-title":"Single LED-based device to perform widefield fluorescence imaging and photodynamic therapy","volume":"9531","author":"Grecco","year":"2015","journal-title":"Proc. SPIE"},{"issue":"11","key":"10.1016\/j.pdpdt.2016.09.002_bib0150","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1111\/ajt.13358","article-title":"Primary prevention of skin dysplasia in renal transplant recipients with photodynamic therapy: a randomized controlled trial","volume":"15","author":"Togsverd-Bo","year":"2015","journal-title":"Am. J. Transplant."},{"issue":"2","key":"10.1016\/j.pdpdt.2016.09.002_bib0155","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s13555-016-0116-7","article-title":"A 10-year retrospective analysis of methyl aminolevulinate photodynamic therapy consultation at the Hospital de Braga","volume":"6","author":"Brito","year":"2016","journal-title":"Dermatol. Ther. (Heidelb.)"}],"container-title":["Photodiagnosis and Photodynamic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S157210001630182X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S157210001630182X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:28:49Z","timestamp":1761611329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S157210001630182X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":31,"alternative-id":["S157210001630182X"],"URL":"https:\/\/doi.org\/10.1016\/j.pdpdt.2016.09.002","relation":{},"ISSN":["1572-1000"],"issn-type":[{"value":"1572-1000","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PDT and emerging therapies for Actinic Keratosis\u2014A resource letter","name":"articletitle","label":"Article Title"},{"value":"Photodiagnosis and Photodynamic Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pdpdt.2016.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}